September 17, 2012 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S ...
September 13, 2012
September 7, 2012 — St. Jude Medical Inc. announced results of the FAME II trial demonstrating that patients with fracti ...
September 07, 2012September 6, 2012 — Daiichi Sankyo Co. Ltd. and Eli Lilly and Co. announced data from the TRILOGY ACS study, a phase III ...
September 06, 2012August 30, 2012 — Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke ...
August 30, 2012
August 30, 2012 — Baseline data from the first cohort of the Global Anticoagulant Registry in the Field (GARFIELD), an ...
August 30, 2012
Feature | Nicole Fornell, Pharm D
A major issue with clopidogrel is that one-third of patients are nonresponders because they lack the enzymes to ...
August 28, 2012
Feature | Antiplatelet and Anticoagulation Therapies | Nicole Fornell, Pharm D
The standard-of-care for dual antiplatelet therapy (DAPT) for more than a decade has been clopidogrel (Plavix) plus ...
August 28, 2012August 23, 2012 — Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, finds that ...
August 23, 2012
August 9, 2012 — The Harvard Clinical Research Institute (HCRI) announced today the successful completion of ...
August 09, 2012July 27, 2012 — Major safety fears over supraventricular tachycardia (SVT) medications are threatening many elderly ...
July 27, 2012July 26, 2012 — Transgenomic Inc. has announced that National Government Services, the designated Medicare fiscal ...
July 26, 2012July 26, 2012 — Angion Biomedica Corp. announced that the first patient was dosed in a Phase II multicenter clinical ...
July 26, 2012July 25, 2012 — Grady Memorial Hospital has standardized and improved patient education and reduced by 75 percent the ...
July 25, 2012July 20, 2012 — Ticagrelor (Brilinta), a blood-thinning drug approved by the U.S. Food and Drug Administration (FDA) in ...
July 20, 2012